58728 Federal Register / Vol. 70, No.
194 / Friday, October 7, 2005 / Notices
MSC 7844, Bethesda, MD 20892, (301) 435–
2212, josephru@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Bioengineering Research Partnerships—
Biomedical Sensing.
Date: October 27, 2005.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Pushpa Tandon, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 7854, Bethesda, MD 20892, (301) 435–
2397, tandonp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RIBT
Member Conflicts.
Date: October 27, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: George M. Barnas, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0696, barnasg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Nuclear
Membrane Proteins.
Date: October 27, 2005.
Time: 2 PM to 3 PM.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health; 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Jonathan Arias, PHD,
Scientific Review Administrator, National
Institutes of Health, 6701 Rockledge Drive,
Room 5170 MSC 7840, Bethesda, MD 20892,
301–435–2406, ariasj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Approaches
in Cancer Therapeutics.
Date: October 27, 2005.
Time: 3 PM to 5 PM.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Joanna M. Watson, PHD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046–G,
MSC 7804, Bethesda, MD 20892, 301–435–
1048, watsonjo@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Aug<31>2005 18:27 Oct 06, 2005 Jkt 208001
Dated: September 30, 2005.
Anthony M. Coelho, Jr.
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20254 Filed 10–6–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: North-2’-Deoxy-
Methanocarbathmydines as Antiviral
Agents Against Poxvirus
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health (NIH), Department
of Health and Human Services (HHS), is
contemplating the grant of an exclusive
license to practice the following
invention as embodied in the following
patent applications: HHS Ref. No. E–
047–2005; U.S. Provisional Patent
Application Number 60/684,811, filed
on May 25, 2005 to N&N Scientific,
having a place of business in Maryland
but incorporated in Illinois. The patent
rights in these inventions have been
assigned to the United States of
America.
DATES: Only written comments and/or
application for a license which are
received by the NIH Office of
Technology Transfer on or before
December 6, 2005 will be considered.
ADDRESSES: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Robert M. Joynes, Office of
Technology Transfer, National Institutes
of Health, 6011 Executive Boulevard,
Suite 325, Rockville, MD 20852–3804;
E-mail: joynesr@od.nih.gov; Telephone:
(301) 594–6565; Facsimile: (301) 402–
0220.
SUPPLEMENTARY INFORMATION: The
prospective exclusive license will be
royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within 60 days from the date of this
published Notice, NIH receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR 404.7. The
field of use may be limited to the
treatment of poxviruses.
PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\07OCN1.SGM
The subject invention relates to a
method for the prevention or treatment
of poxvirus infection by administering
an effective amount of an antiviral agent
comprising a carbocyclic 2’-
deoxynucleoside analog (as described in
U.S. Patent Nos. 5,629,454 and
5,869,666) to an individual in need
thereof. North-methanocarbathymidine
(N–MCT), a thymidine analog with a
pseudosugar moiety locked in the
northern conformation, which was
previously shown to exert strong
activity against herpes simplex virus
types 1 and 2, has been identified as
exhibiting potent activity against
poxviruses. N–MCT effectively blocks
poxvirus synthesis through its
phosphorylated metabolite, which is
more efficiently produced in poxvirus-
infected cells. This compound is
approximately seven times more potent
than cidofovir against vaccinia and
cowpox in cell culture. The higher
potency and target specificity of N–MCT
against poxvirus, as well as its high
margin of safety, makes it a highly
desirable agent against the poxviridae
family. In addition, the mechanism of
N–MCT may be different from that of
cidofovir, making it even more desirable
due to the scarcity of the potential
available efficacious anti-pox agents
currently under development.
The licensed territory will be
exclusive worldwide.
Properly filed competing applications
for a license filed in response to this
notice will be treated as objections to
the contemplated license. Comments
and objections submitted in response to
this notice will not be made available
for public inspection, and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: September 27, 2005.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 05–20242 Filed 10–6–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
Senior Executive Service Performance
Review Board
AGENCY: Office of the Secretary, DHS.
ACTION: Notice.
SUMMARY: This notice announces the
appointment of the members of the
Senior Executive Service Performance
07OCN1
 Federal Register / Vol. 70, No. 194 / Friday, October 7, 2005 / Notices 58729

Review Boards for the Department of Dunlap, James L. Stenger, Michael C.

Homeland Security. The purpose of the Fagerholm, Eric N. Stephan, Robert B.
Performance Review Board is to review Filler, Joshua D. Stephens, Michael P.
and make recommendations concerning Forman, Marcy M. Sullivan, Daniel
proposed performance appraisals, Fonash, Peter M. Sullivan, Mark J.
ratings, bonuses, pay adjustments, and Hale, Janet Sutherland, Daniel W.
other appropriate personnel actions for Hall, Michael J. Tambone, Victor J.
incumbents of Senior Executive Service Hasting, Charles R. Teufel, Hugo
positions of the Department. Hastings, Scott O. Thomson, E. Keith
EFFECTIVE DATES: This Notice is effective Hill, Kenneth Torres, John
October 7, 2005. Holcomb, Lee B. Trissell, David A.
Irving, Paul D. Turner, Pamela J.
FOR FURTHER INFORMATION CONTACT:
James, Ronald J. Turner, Todd H.
Carmen Arrowood, Office of the Chief Jones, Rendell L.
Human Capital Office, telephone (202) Vanacore, Michael J.
Kelleher, John J. Venuto, Kenneth T. RADM
357–8348. Kent, Donald H. Vint, Norbert E.
SUPPLEMENTARY INFORMATION: Each Khatri, Prakash I. Walker, Carmen H.
Federal agency is required to establish Kubricky, John J. Weber, Robert W.
one or more performance review boards Kunkel, David W. RADM West, Robert C.
(PRB) to make recommendations, as Ladd, Paul E. Whitehead, Joel R. RDML
necessary, in regard to the performance Lang, Gary J. Whitford, Richard A.
of senior executives within the agency. Langlois, Joseph E. Wiggins, Michael
5 U.S.C. 4314(c). This notice announces Lederer, Calvin M. Williams, Dwight
the appointment of the members of the Lockwood, Thomas Williams, James A.
PRB for the Department of Homeland Lumsden, Sheila Williams, Richard N.
Security (DHS). The purpose of the PRB Lynch, Dennis F. Wood, John F.
is to review and make recommendations MacDonald, John R. Woodson, Mary Ann
concerning proposed performance Mandelker, Sigal P.
appraisals, ratings, bonuses, pay Maner, Andrew B. This notice does not constitute a
adjustments, and other appropriate Martinez-Fonts, Alfonso significant regulatory action under
personnel actions for incumbents of SES Matticks, John section 3(f) of Executive Order 12866.
positions within DHS. Maursstad, David I. Therefore, DHS has not submitted this
The Board shall consist of at least Mayer, Matt A. notice to the Office of Management and
three members. In the case of an McCampbell, Christy Budget. Further, because this notice is a
appraisal of a career appointee, more McCarthy, Maureen I. matter of agency organization,
than half of the members shall consist McDonald, Sallie procedure and practice, DHS is not
of career appointees. Composition of the McKennis, Amy D. required to follow the rulemaking
specific PRBs will be determined on an McNamara, John C. requirements under the Administrative
ad hoc basis from among the individuals McQueary, Charles E. Procedure Act (5 U.S.C. 553).
listed below: Mitchell, Andrew Dated: September 30, 2005.
Adamoli, Joseph B. Mocny, Robert A. Rodney Markham,
Adams, Audrey L. Nagel, Brian K. Director, Executive Resources, Office of the
Aguilar, David V. Nimmich, Joseph L. RDML Chief Human Capital Office.
Ahern, Jayson P. O’Neill, James P. [FR Doc. 05–20167 Filed 10–6–05; 8:45 am]
Alexander, Jane A. O’Reilly, Terrance M. BILLING CODE 4410–10–P
Arcos, Cresencio Ostergaard, Daniel J.
Balaban, Richard L. Oxford, Vayl S.
Bathurst, Donald G. Paar, Thomas C. DEPARTMENT OF HOMELAND
Beardsworth, Richard Parent, Wayne SECURITY
Bergman, Cynthia L. Prewitt, Keith L.
Besanceney, Brian R. Prillaman, K. Gregg Coast Guard
Blair, James D. Quinn, Thomas
Bone, Craig, E. RADML Reyes, Juan DEPARTMENT OF TRANSPORTATION
Boudreaux, Chad Richmond, Susan
Boyd, David G. Riggs, Barbara S. Maritime Administration
Brice-O’Hara, Sally RADM Robles, Alfonso
[USCG–2005–22611]
Broderick, Matthew E. Rogers, George D.
Buikema, Edward G. Rossides, Gale D. Neptune LNG, L.L.C., Liquefied Natural
Cannatti, Ashley Rothwell, Gregory D. Gas Deepwater Port License
Charbo, Lawrence Scott Runge, Jeffrey W. Application
Cira, Anthony Thomas Santana, Catherine Y.
Cuddihy, Joseph D. Schied, Eugene H. AGENCY: Coast Guard, DHS; Maritime
Currier, John P. RADML Schmitz, Michael T. Administration, DOT.
DiGregorio, Elizabeth L. Shingler, Wendell C. ACTION: Notice of application.
Dinanno, Thomas G. Sirois, R. Dennis RADM
Dolan, Kay Frances Smith, Robert M. SUMMARY: The Coast Guard and the
Dooher, John C. Sposato, Janis A. Maritime Administration (MARAD)
Duke, Elaine C. Stalhschmidt, Patricia K. announce that they have received an
Dunham, Carol A. Stallworth, Charles E. application for the licensing of a

VerDate Aug<31>2005 18:27 Oct 06, 2005 Jkt 208001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\07OCN1.SGM 07OCN1